Leukemia inhibitory factor is a therapeutic target for renal interstitial fibrosis

BACKGROUND: The role of the IL6 family members in organ fibrosis, including renal interstitial fibrosis (TIF), has been widely explored. However, few studies have ever simultaneously examined them in the same cohort of patients. Besides, the role of leukemia inhibitory factor (LIF) in TIF remains un...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Shihui, Yang, Xiaobing, Chen, Qingzhou, Liu, Zhuoliang, Chen, Ying, Yao, Xiaotian, Xiao, An, Tian, Jianwei, Xie, Liling, Zhou, Miaomiao, Hu, Zheng, Zhu, Fengxin, Xu, Xin, Hou, Fanfan, Nie, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9646860/
https://www.ncbi.nlm.nih.gov/pubmed/36335669
http://dx.doi.org/10.1016/j.ebiom.2022.104312

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9646860/
https://www.ncbi.nlm.nih.gov/pubmed/36335669
http://dx.doi.org/10.1016/j.ebiom.2022.104312

Ejemplares similares